Facet Technologies is a FDA registered, ISO 13485:2003 certified engineering and manufacturing company. Facet's specialty is in development of new, innovative, hand-held medical devices that are designed to offer precision and intuitive performance in the hands of the patient and/or healthcare professional.Facet has proven achievement through its close partnerships with major OEM's for the design and distribution of diabetes products and safety devices to the marketplace.

Facet Technologies LLC

VP of Finance

Treasurer

Financial Analyst

Financial Accountant

Assembler

Sorter

Sewing machine operator

Molding machine operator

Automation Engineer

Engineering mgr, IT mgr

Assy Mgr , Maint Engineer

Maintenance Manager

Automotive Technician

Plant Engineering Mechanic

Automation Technician

Reliability Tech

supervisor tooling

Lead moldmaker

tool and die maker / mold maker

Sr. Administrative Asst.

Maintenance Supervisor

Senior Manufacturing Engineering Manager

Senior Manufacturing Engineer

Engineering Technician Maintenance Supervisor

Supervisor of Technical Operations

Quality Lead

Lab Supervisor

Sr. Human Resources Manager

Site Human Resource Business Partner

Regional Human Resources Business Partner

Human Resource Rep

Microsoft Office 365

Mobile Friendly

Google Font API

Nginx

WordPress.org

Remote

Poxel is a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and rare disorders. Poxel has clinical and earlier-stage programs from its adenosine monophosphate-activated protein kinase (AMPK) activator and deuterated TZD platforms targeting chronic and rare metabolic diseases. For the treatment of NASH, PXL065 (deuterium-stabilized R-pioglitazone) is in a streamlined Phase 2 trial (DESTINY1). PXL770, a first-in-class direct AMPK activator, has successfully completed a Phase 2a proof-of-concept trial for the treatment of NASH, which met its objectives. For the rare inherited metabolic disorder, adrenoleukodystrophy (ALD), the company intends to initiate Phase 2a proof of concept studies with PXL065 and PXL770 in patients with adrenomyeloneuropathy (AMN). TWYMEEG® (Imeglimin), Poxel's first-in-class lead product that targets mitochondrial dysfunction, has been approved and launched for the treatment of type 2 diabetes in Japan. Poxel expects to receive sales-based payments and royalties from Sumitomo Dainippon Pharma. Poxel has a strategic partnership with Sumitomo Dainippon Pharma for Imeglimin in Japan, China, South Korea, Taiwan and nine other Southeast Asian countries. The Company intends to generate further growth through strategic partnerships and pipeline development. Listed on Euronext Paris, Poxel is headquartered in Lyon, France, and has subsidiaries in Boston, MA, and Tokyo, Japan.

POXEL

Amazon AWS

Apache

Data Analytics

Denise Beaubois

VP of Finance at Facet Technologies LLC

Denise Beaubois' Professional Contact Details

Denise Beaubois' Current Company Details

Facet Technologies LLC

Denise Beaubois' Work History and Education

Frequently Asked Questions about Denise Beaubois

What company does Denise Beaubois work for?

What is Denise Beaubois' role at Facet Technologies LLC?

What is Denise Beaubois' email address?

What is Denise Beaubois' business email address?

What is Denise Beaubois' HQ phone number?

What industry does Denise Beaubois work in?

Who are Denise Beaubois' colleagues?

Colleagues at Facet Technologies LLC

Prospect on LinkedIn

People Search

Company Search

Erik Straub

Michael Transon

Ready to try it out?